Enzo Biochem earnings were -$21.3M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. The latest ENZ earnings report on Jan 31, 2025 announced Q1 2025 earnings of -$1.5M, down 54.5% from last quarter. For the last reported fiscal year 2024 ending Jul 31, 2024, ENZ reported annual earnings of -$26.1M, with -228.5% growth.
On ENZ's earnings call on Invalid Date, Enzo Biochem (NYSE: ENZ) reported Q4 2024 earnings per share (EPS) of -$0.03, up 50% year over year. Total ENZ earnings for the quarter were -$1.54 million. In the same quarter last year, Enzo Biochem's earnings per share (EPS) was -$0.06.
As of the last Enzo Biochem earnings report, Enzo Biochem is currently losing money. Enzo Biochem's net profit (also called net income) for the twelve months ending Jan 31, 2025 was -$21.31 million, a 165.44% decrease year over year.
What was ENZ's earnings growth in the past year?
As of Enzo Biochem's earnings date in Invalid Date, Enzo Biochem's earnings has grown year over year. ENZ earnings in the past year totalled -$21.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.